Allergan Sales, LLC
FDA inspection history in Irvine, California, 2010
- 1
- Form 483
Every document, by year
- Form 483
2010: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2010One Form 483, at Irvine, California.
Cited most
Across all Allergan Sales observations on file
- 21 CFR 314.80(c)(1)(i)Postmarketing reporting of adverse drug experiences2
- 21 CFR 314.81(b)(2)Other postmarketing reports1
The complete Allergan Sales file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Irvine, California
One Form 483 · 2010 · 3 observations
Latest: Form 483, Jul 9, 2010 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2010-07-09 | 483 Form 483 | Irvine, California | 3 | $99 |
Investigators on these documents
FEI number 2011068 · most recent document Jul 9, 2010
About Allergan Sales, LLC
How many FDA Form 483s has Allergan Sales, LLC received?
FDA Intel has 1 Form 483 on file for Allergan Sales, LLC; the most recent is dated Jul 9, 2010.
When was Allergan Sales, LLC last inspected by FDA?
The most recent FDA inspection document on file for Allergan Sales, LLC is a Form 483 dated Jul 9, 2010, for the site in Irvine, California.
What did FDA cite at Allergan Sales, LLC?
The regulations cited most in the observations on file for Allergan Sales, LLC are 21 CFR 314.80(c)(1)(i) (Postmarketing reporting of adverse drug experiences), 2 times; 21 CFR 314.81(b)(2) (Other postmarketing reports), 1 time.